Randy C. Hatton

1.5k total citations
46 papers, 1.1k citations indexed

About

Randy C. Hatton is a scholar working on Pediatrics, Perinatology and Child Health, Geriatrics and Gerontology and Pharmacology. According to data from OpenAlex, Randy C. Hatton has authored 46 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pediatrics, Perinatology and Child Health, 11 papers in Geriatrics and Gerontology and 8 papers in Pharmacology. Recurrent topics in Randy C. Hatton's work include Pharmaceutical Practices and Patient Outcomes (11 papers), Pharmaceutical studies and practices (11 papers) and Patient Safety and Medication Errors (4 papers). Randy C. Hatton is often cited by papers focused on Pharmaceutical Practices and Patient Outcomes (11 papers), Pharmaceutical studies and practices (11 papers) and Patient Safety and Medication Errors (4 papers). Randy C. Hatton collaborates with scholars based in United States, Thailand and Australia. Randy C. Hatton's co-authors include Almut G. Winterstein, Ricardo J. Gonzalez‐Rothi, Thomas E. Johns, Richard Segal, Penkarn Kanjanarat, Paul L. Doering, Kristin Weitzel, Leslie Hendeles, Regino P. González‐Peralta and Olga Bessmertny and has published in prestigious journals such as Statistics in Medicine, American Journal of Kidney Diseases and Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy.

In The Last Decade

Randy C. Hatton

45 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Randy C. Hatton United States 18 439 258 242 176 122 46 1.1k
A.W. Lenderink Netherlands 14 458 1.0× 318 1.2× 178 0.7× 176 1.0× 65 0.5× 20 1.2k
Cate Whittlesea United Kingdom 18 467 1.1× 267 1.0× 161 0.7× 91 0.5× 261 2.1× 62 1.3k
Jim Lloyd United States 5 332 0.8× 330 1.3× 150 0.6× 196 1.1× 124 1.0× 7 1.1k
J. Lyle Bootman United States 13 516 1.2× 151 0.6× 191 0.8× 111 0.6× 149 1.2× 52 1.1k
Anne Gerd Granås Norway 20 595 1.4× 157 0.6× 364 1.5× 164 0.9× 206 1.7× 61 1.2k
Jacob Abarca United States 15 682 1.6× 287 1.1× 209 0.9× 158 0.9× 125 1.0× 31 1.2k
Terry S. Field United States 14 366 0.8× 176 0.7× 109 0.5× 89 0.5× 148 1.2× 21 1.3k
Rachel L. Howard United Kingdom 10 554 1.3× 186 0.7× 194 0.8× 235 1.3× 122 1.0× 15 952
Leslie Fish United States 13 1.2k 2.7× 416 1.6× 345 1.4× 328 1.9× 228 1.9× 16 1.9k
Jerry L. Bauman United States 24 366 0.8× 144 0.6× 209 0.9× 196 1.1× 106 0.9× 108 2.1k

Countries citing papers authored by Randy C. Hatton

Since Specialization
Citations

This map shows the geographic impact of Randy C. Hatton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Randy C. Hatton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Randy C. Hatton more than expected).

Fields of papers citing papers by Randy C. Hatton

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Randy C. Hatton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Randy C. Hatton. The network helps show where Randy C. Hatton may publish in the future.

Co-authorship network of co-authors of Randy C. Hatton

This figure shows the co-authorship network connecting the top 25 collaborators of Randy C. Hatton. A scholar is included among the top collaborators of Randy C. Hatton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Randy C. Hatton. Randy C. Hatton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hatton, Randy C. & Leslie Hendeles. (2025). What we have learned from trying to remove oral phenylephrine from the market. JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY. 8(3). 214–223.
2.
Hatton, Randy C. & Leslie Hendeles. (2022). Why Is Oral Phenylephrine on the Market After Compelling Evidence of Its Ineffectiveness as a Decongestant?. Annals of Pharmacotherapy. 56(11). 1275–1278. 4 indexed citations
3.
Hatton, Randy C., et al.. (2022). Countries Manufacturing Pharmaceuticals for the US Market: A 10-Year Analysis of Public Data. Annals of Pharmacotherapy. 56(10). 1106–1112. 4 indexed citations
4.
Staley, Benjamin, et al.. (2013). Evaluating Incorporation of Drug Restrictions into Computerized Drug Order Entries after Transition to an Electronic Health Record. Hospital Pharmacy. 48(7). 568–573. 3 indexed citations
5.
Reid, C., Randy C. Hatton, & Paul M Middleton. (2011). Case report: prehospital use of intranasal ketamine for paediatric burn injury. Emergency Medicine Journal. 28(4). 328–329. 29 indexed citations
6.
Winterstein, Almut G., et al.. (2008). An evaluation of the effects of gatifloxacin on glucose homeostasis. Pharmacy World & Science. 30(5). 544–549. 11 indexed citations
7.
Hendeles, Leslie, et al.. (2005). Automatic replacement of albuterol nebulizer therapy by metered-dose inhaler and valved holding chamber. American Journal of Health-System Pharmacy. 62(10). 1053–1061. 25 indexed citations
8.
Hatton, Randy C., et al.. (2004). Evaluation of Online Drug References for Identifying Over-the-Counter Solid Oral Dosage Forms. Journal of the American Pharmacists Association. 44(6). 694–699. 8 indexed citations
9.
Winterstein, Almut G., Thomas E. Johns, Eric I. Rosenberg, et al.. (2004). Nature and causes of clinically significant medication errors in a tertiary care hospital. American Journal of Health-System Pharmacy. 61(18). 1908–1916. 85 indexed citations
10.
Smith, Wendy D., et al.. (2004). Evaluation of Drug Interaction Software to Identify Alerts for Transplant Medications. Annals of Pharmacotherapy. 39(1). 45–50. 20 indexed citations
11.
Hatton, Randy C., et al.. (2000). Hand-Held Drug Information: Applications for Hospital Pharmacists. Journal of the American Pharmaceutical Association (1996). 40(6). 841–842. 1 indexed citations
12.
Hatton, Randy C.. (2000). Bismuth Subgallate–Epinephrine Paste in Adenotonsillectomies. Annals of Pharmacotherapy. 34. 522–525. 2 indexed citations
13.
Hatton, Randy C.. (2000). Bismuth Subgallate–Epinephrine Paste in Adenotonsillectomies. Annals of Pharmacotherapy. 34(4). 522–525. 15 indexed citations
14.
Buring, Shauna M., et al.. (1999). Discontinuation Rates of Helicobacter pylori Treatment Regimens: A Meta‐Analysis. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 19(3). 324–332. 24 indexed citations
15.
Hatton, Randy C., et al.. (1996). Pharmacoeconomic evaluation of anesthesia in ambulatory surgery: comparison of desflurane to isoflurane and propofol.. PubMed. 16(2). 71–85. 1 indexed citations
16.
Hatton, Randy C., et al.. (1995). Removal of iron dextran by hemodialysis: An in vitro study. American Journal of Kidney Diseases. 26(2). 327–330. 14 indexed citations
17.
Doering, Paul L., et al.. (1994). Use of Nifedipine in the Hypertensive Diseases of Pregnancy. Annals of Pharmacotherapy. 28(12). 1371–1378. 10 indexed citations
18.
Hatton, Randy C., et al.. (1991). Influence of methods on the evaluation of therapeutic drug-monitoring services.. PubMed. 48(7). 1553–9. 1 indexed citations
19.
Hatton, Randy C., et al.. (1984). Comparison of the Predictions of One- and Two-Compartment Microcomputer Programs for Long-Term Tobramycin Therapy. Therapeutic Drug Monitoring. 6(4). 432–437. 4 indexed citations
20.
Hatton, Randy C., Paul L. Doering, & Jaime L. Frías. (1982). Physicians' Sources of Information about Teratogenic Effects of Drugs. Drug Information Journal. 16(3). 148–156. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by A.W. Lenderink Breakdown of academic impact, for papers by Cate Whittlesea Breakdown of academic impact, for papers by Jim Lloyd Breakdown of academic impact, for papers by J. Lyle Bootman Breakdown of academic impact, for papers by Anne Gerd Granås Breakdown of academic impact, for papers by Jacob Abarca Breakdown of academic impact, for papers by Terry S. Field Breakdown of academic impact, for papers by Rachel L. Howard Breakdown of academic impact, for papers by Leslie Fish Breakdown of academic impact, for papers by Jerry L. Bauman
Rankless by CCL
2026